6,11-3C-bicyclic 9a-azalide derivatives
    41.
    发明授权
    6,11-3C-bicyclic 9a-azalide derivatives 失效
    6,11-3C-双环9a-氮杂的衍生物

    公开(公告)号:US06645941B1

    公开(公告)日:2003-11-11

    申请号:US10397923

    申请日:2003-03-26

    IPC分类号: A61K3170

    CPC分类号: C07H17/08

    摘要: The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.

    摘要翻译: 本发明公开了式I化合物或其药学上可接受的盐,酯或前药:其表现出抗菌性质。 本发明还涉及包含上述化合物的药物组合物,用于给予需要抗生素治疗的受试者。 本发明还涉及通过施用包含本发明化合物的药物组合物来治疗受试者的细菌感染的方法。 本发明还包括制备本发明化合物的方法。

    9-amino-14-membered macrolides derived from leucomycins
    42.
    发明授权
    9-amino-14-membered macrolides derived from leucomycins 失效
    衍生自莱可霉素的9-氨基-14-元大环内酯类

    公开(公告)号:US06436906B1

    公开(公告)日:2002-08-20

    申请号:US09824318

    申请日:2001-04-02

    IPC分类号: A61K3170

    CPC分类号: C07H17/08 A61K31/70

    摘要: Novel 9-amino-14-membered macrolides and pharmaceutically-acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention and processes for the preparation of such compounds.

    摘要翻译: 新型9-氨基-14-元大环内酯和药学上可接受的组合物,其包含治疗有效量的本发明化合物与药学上可接受的载体的组合,通过向哺乳动物施用药物组合物来治疗细菌感染的方法, - 本发明化合物的有效量和制备这些化合物的方法。

    C-2 modified erythromycin derivatives
    43.
    发明授权
    C-2 modified erythromycin derivatives 有权
    C-2修饰红霉素衍生物

    公开(公告)号:US06355620B1

    公开(公告)日:2002-03-12

    申请号:US09312517

    申请日:1999-05-14

    IPC分类号: A61K3170

    CPC分类号: C07H17/08

    摘要: A compound having the formula selected from the group consisting of a compound of formula I a compound of formula II a compound of formula III as well as and pharmaceutically acceptable salts, esters, solvates, metabolites, and prodrugs thereof, are useful in treating bacterial infections. Also provided are pharmaceutically acceptible compositions, methods of treating bacterial infections, and processes for the preparation of the compounds.

    摘要翻译: 具有下式的化合物选自式Ia化合物式IIa化合物式III化合物及其药学上可接受的盐,酯,溶剂合物,代谢物和前药,可用于治疗细菌感染。 还提供了药学上可接受的组合物,治疗细菌感染的方法和化合物的制备方法。

    6-11 Bridged Oxime Erythromycin Derivatives
    44.
    发明申请
    6-11 Bridged Oxime Erythromycin Derivatives 审中-公开
    6-11桥接肟红霉素衍生物

    公开(公告)号:US20080262208A1

    公开(公告)日:2008-10-23

    申请号:US12123874

    申请日:2008-05-20

    IPC分类号: C07H17/08

    CPC分类号: C07H17/08

    摘要: The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes processes by which to make the compounds of the present invention.

    摘要翻译: 本发明公开了式I化合物或其药学上可接受的盐,酯或前药:其表现出抗菌性质。 本发明还涉及包含上述化合物的药物组合物,用于给予需要抗生素治疗的受试者。 本发明还涉及通过施用包含本发明化合物的药物组合物来治疗受试者的细菌感染的方法。 本发明还包括制备本发明化合物的方法。

    6-11 bridged oxime erythromycin derivatives
    45.
    发明授权
    6-11 bridged oxime erythromycin derivatives 有权
    6-11桥接肟红霉素衍生物

    公开(公告)号:US07384922B2

    公开(公告)日:2008-06-10

    申请号:US11416609

    申请日:2006-05-03

    IPC分类号: A61K31/70 C07H17/08

    CPC分类号: C07H17/08

    摘要: The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes processes by which to make the compounds of the present invention.

    摘要翻译: 本发明公开了式I化合物或其药学上可接受的盐,酯或前药:其表现出抗菌性质。 本发明还涉及包含上述化合物的药物组合物,用于给予需要抗生素治疗的受试者。 本发明还涉及通过施用包含本发明化合物的药物组合物来治疗受试者的细菌感染的方法。 本发明还包括制备本发明化合物的方法。

    9A, 11-2C-bicyclic 9a-azalide derivatives
    46.
    发明授权
    9A, 11-2C-bicyclic 9a-azalide derivatives 有权
    9A,11-2C-双环9a-氮杂环戊二烯衍生物

    公开(公告)号:US07271155B2

    公开(公告)日:2007-09-18

    申请号:US11324502

    申请日:2006-01-03

    IPC分类号: A61K31/70 C07H17/08

    CPC分类号: C07H17/08

    摘要: The present invention discloses compounds of formulae I and II, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.

    摘要翻译: 本发明公开了式I和II的化合物或其药学上可接受的盐,酯或前药:其表现出抗菌性质。 本发明还涉及包含上述化合物的药物组合物,用于给予需要抗生素治疗的受试者。 本发明还涉及通过施用包含本发明化合物的药物组合物来治疗受试者的细菌感染的方法。 本发明还包括制备本发明化合物的方法。

    6,11-4C-bicyclic 9a-azalide derivatives
    47.
    发明授权
    6,11-4C-bicyclic 9a-azalide derivatives 失效
    6,11-4C-双环9a-氮杂的衍生物

    公开(公告)号:US06764998B1

    公开(公告)日:2004-07-20

    申请号:US10464188

    申请日:2003-06-18

    IPC分类号: A61K3170

    CPC分类号: C07H17/08

    摘要: The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.

    摘要翻译: 本发明公开了式I化合物或其药学上可接受的盐,酯或前药:其表现出抗菌性质。 本发明还涉及包含上述化合物的药物组合物,用于给予需要抗生素治疗的受试者。 本发明还涉及通过施用包含本发明化合物的药物组合物来治疗受试者的细菌感染的方法。 本发明还包括制备本发明化合物的方法。

    4'-substituted leucomycins
    48.
    发明授权
    4'-substituted leucomycins 失效
    4'-取代的莱可霉素

    公开(公告)号:US06680299B2

    公开(公告)日:2004-01-20

    申请号:US09917107

    申请日:2001-07-27

    IPC分类号: A61K3170

    CPC分类号: C07H17/08

    摘要: There are described novel 4′ substituted 16-membered macrolides and pharmaceutically acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier. Also described are a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention, and processes for the preparation of such compounds.

    摘要翻译: 描述了新颖的4'取代的16元大环内酯和药学上可接受的组合物,其包含治疗有效量的本发明化合物与药学上可接受的载体的组合。 还描述了通过向哺乳动物施用含有治疗有效量的本发明化合物的药物组合物以及制备这些化合物的方法来治疗细菌感染的方法。

    2-Halo-6-O-substituted ketolide derivatives
    50.
    发明授权
    2-Halo-6-O-substituted ketolide derivatives 失效
    2-卤代-6-O-取代的酮内酯衍生物

    公开(公告)号:US6124269A

    公开(公告)日:2000-09-26

    申请号:US154294

    申请日:1998-09-16

    IPC分类号: C07H17/08 A61K31/70

    CPC分类号: A61K31/7048 C07H17/08

    摘要: Novel 2-halo-6-O-substituted ketolide derivatives and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula ##STR1## compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention, and processes for their preparation.

    摘要翻译: 具有抗菌活性的新型2-卤代-6-O-取代的酮内酯衍生物及其药学上可接受的盐和酯,其具有包含治疗有效量的本发明化合物与药学上可接受的载体的组合物的组合物,治疗细菌的方法 通过向哺乳动物施用含有治疗有效量的本发明化合物的药物组合物及其制备方法的感染。